PAR DRUGS AND CHEM LTD Peer Comparison
PAR · Healthcare · Current price ₹168.26
Peers tracked
11
PAR DRUGS AND CHEM LTD P/E
15.5x
Sector
Healthcare
PAR DRUGS AND CHEM LTD vs peers
| Company | Price | P/E | Market cap (Cr) |
|---|---|---|---|
| SUN PHARMACEUTICAL IND L | ₹1,929 | 39.1x | 4,62,592 |
| DIVI S LABORATORIES LTD | ₹9,165 | 69.1x | 2,46,328 |
| TORRENT PHARMACEUTICALS L | ₹4,965.5 | 72.9x | 1,90,640 |
| ZYDUS LIFESCIENCES LTD | ₹1,167.8 | 22.0x | 1,15,132 |
| CIPLA LTD | ₹1,423 | 30.3x | 1,14,134 |
| LAURUS LABS LIMITED | ₹1,861.6 | 92.8x | 1,00,120 |
| LUPIN LIMITED | ₹2,153 | 20.6x | 98,042 |
| MANKIND PHARMA LIMITED | ₹2,356.5 | 53.7x | 97,970 |
| DR. REDDY S LABORATORIES | ₹1,171 | 26.8x | 96,760 |
| AUROBINDO PHARMA LTD | ₹1,683.3 | 25.9x | 94,834 |
| PAR DRUGS AND CHEM LTD | ₹140.6 | 8.4x | 206 |
PAR DRUGS AND CHEM LTD versus its peers
PAR DRUGS AND CHEM LTD operates in the Healthcare space alongside 11 tracked peers. Comparing valuation multiples within a sector is far more meaningful than in isolation — a P/E of 15.5x may be cheap in one industry and expensive in another.
More on PAR DRUGS AND CHEM LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.